Related references
Note: Only part of the references are listed.Relationship Between Drug Resistance and Death in HIV-Infected Patients Receiving Antiretroviral Therapy 7 PLADs, China, 2010-2019
Tianhao Zhang et al.
CHINA CDC WEEKLY (2021)
Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study
Ankur Gupta-Wright et al.
LANCET HIV (2020)
Alcohol-related intentional nonadherence to antiretroviral therapy among people living with HIV, Cape Town, South Africa
Seth Kalichman et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2019)
Drug resistance mutation profiles of the drug-na⟨ve and first-line regimen-treated HIV-1-infected population of Suzhou, China
Tingting Li et al.
VIROLOGICA SINICA (2017)
Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China
Zhongbao Zuo et al.
PLOS ONE (2016)
Efficacy and safety of treatment simplification to atazanavir/ritonavir plus lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study
A. Mondi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
Jose R. Arribas et al.
LANCET INFECTIOUS DISEASES (2015)
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
Jose A. Perez-Molina et al.
LANCET INFECTIOUS DISEASES (2015)
Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir plus emtricitabine/lamivudine plus efavirenz administered on a multiple tablet therapy
Jose L. Blanco et al.
AIDS (2014)
A Multicenter Study of Initiation of Antiretroviral Therapy and Transmitted Drug Resistance in Antiretroviral-Naive Adolescents and Young Adults With HIV in New York City
Christina Gagliardo et al.
CLINICAL INFECTIOUS DISEASES (2014)
Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014
Michaela Rappold et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2014)
Impact of HIV drug resistance on virologic and immunologic failure and mortality in a cohort of patients on antiretroviral therapy in China
Lingjie Liao et al.
AIDS (2013)
Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India
Gerardo Alvarez-Uria et al.
GLOBAL HEALTH ACTION (2013)
Surveys of Transmitted HIV Drug Resistance in 7 Geographic Regions in China, 2008-2009
Lingjie Liao et al.
CLINICAL INFECTIOUS DISEASES (2012)
HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries
Diane E. Bennett et al.
CLINICAL INFECTIOUS DISEASES (2012)
Evaluation of HIV-1 resistance to antiretroviral drugs among 150 patients after six months of therapeutic interruption
E. M. N. Kalmar et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2012)
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
AD Monforte et al.
AIDS (2000)
Share Paper
